{# ── Billing problem banner: payment failed (past_due) or retries exhausted (unpaid). Pro access is gated off by is_pro until the card is fixed, so prompt the user to update billing. ── #}

Red Flags Detected

  • Delisting (new) — Company received formal Nasdaq delisting notice due to stockholders' equity deficiency below $2.5 million as of March 31, 2026.
NASDAQ: ENSCW Ensysce Biosciences, Inc. 8-K

Ensysce Biosciences receives Nasdaq delisting notice for equity deficiency below $2.5M

Filed May 22, 2026 · Period ending May 22, 2026 · ~1 min read

3 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade ENSCW commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Feedback
View original filing on SEC.gov

Generated by AI · May 26, 2026 11:35 AM